AKT1 and cancer: Considering the crucial role of hyperactive Akt, driven by oncogenes, in cancer cell survival and resistance to therapy [18], identifying vulnerabilities within specific subsets of cancer cells can pave the way for tailored therapies targeting oncogene-addicted cancer cells.